73590-58-6 (奥美拉唑,Omeprazole)

奥美拉唑;5-甲氧基-2-{[(4-甲氧基-3,5-二甲基-2-吡啶基)-甲基]-亚砜}-1H-苯并咪唑;奥克;洛赛克;5-甲氧基-2-[(4-甲氧基-3,5-二甲基-2-吡啶基)-甲基亚砜]-3H-苯并咪唑;洛塞克;欧麦亚砜;亚砜米唑;奥美拉唑 GMP;3-氰基苯甲酰氯;Omeprazole 奥美拉唑;WAKO155-02921奥美拉唑标准品;奥美拉唑 USP标准品;奥美拉唑 标准品;奥美拉唑 技术转让;奥美拉唑,0;奥美拉唑肠溶胶囊一致性评价技术服务;奥美拉唑峰鉴别 EP标准品;奥美拉唑及杂质;奥美拉唑钠;奥美拉唑微丸;奥美拉唑原药;奥美拉唑杂质;奥美拉唑杂质对照品;5-甲氧基-2-[(4-甲氧基-3,5-二甲基-2-吡啶基)-甲基亚砜]-1H-苯并咪唑;艾美拉唑;奥美拉唑, 洛赛克;奥咪拉唑;亚砜咪唑;左旋奥美拉唑;5-甲氧基-2-[[(4-甲氧基-3,5-二甲基-2-吡啶基)甲基]亚磺酰]-1H-苯并咪唑;奥利万星;炎琥宁;奥美拉唑肠溶微丸(中间体);奥美拉唑D3;奥美拉挫;奥美拉唑峰鉴别;

Omeprazole;1h-benzimidazole,5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulf;2-Chloromethyl-3,5-dinmethyl-4-methoxypyridine;5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazol;audazol;aulcer;belmazol;ceprandal;elgam;(RS)-5-Methoxy-2-(4-methoxy-3,5-dimethyl-2-pyridylmethylsulphinyl)benzimidazole;Omeprazole solution;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulphinyl]-1H-benzimidazole;5-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)-methylsulfinyl]benzimidazole;5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulphinyl]-1H-benzimidazole;5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole;Losec;MEPRAL;miol;prysma;ulcsep;zimor;ZOLTUM;6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole;5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole;Antra;5-Methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3H-benzoimidazole;Vancomycin,22-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-arabino-hexopyranosyl)-N3''-[(4'-chloro[1,1'-biphenyl]-4-yl)methyl]-,(4''R)-;Prilosec;Esomeprazole;Omeprazon;Parizac;Omepral;Omapren;Zegerid;Mopral;Ulcometion;Pepticum;Inhipump;Gastrimut;Sanamidol;Prazidec;Secrepina;Peptilcer;Inhibitron;Gibancer;Dudencer;Dizprazol;Logastric;Indurgan;Gastroloc;Epirazole;Emeproton;Ulceral;Ozoken;Ulcozol;Ulcesep;Omizac;Ramezol;Omisec;Omezol;Zefxon;Ompanyt;Omeprol;Miracid;Desec;Ultop;Ulsen;Lomac;Omid;Omed;Ocid;OMEP;Regulacid;Prazentol;Demeprazo;H 16868;Procelac;BRD-A88691025-001-07-4;1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-;FT-0601585;Omeprazolum [INN-Latin];Prestwick_808;AKOS005066653;Omeprazole (JP17/USP/INN);(omeprazole)5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole;MLS006011759;OMEPRAZOLE [MART.];Omesec;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole;6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole;Omebeta 20;Emilok;Esomeprazole Sodium;Gastrogard;6-methoxy-2-(((4-methoxy-3,5-dimethyl pyridin-2-yl)methyl)sulfinyl)-1h-benzo[d]imidazole;Tox21_110686_1;EN300-117238;MLS001076112;FT-0653294;BO164173;D00455;CHEBI:77260;SR-01000003003-4;NCGC00016925-05;(-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole;Omeprazone;CCG-213517;5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole;OMEPRAZOLE [WHO-DD];NCGC00016925-11;OMEPRAZOLE (MART.);Nopramin;Omezolan;NSC-759192;(RS)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole;BCP13592;NCGC00016925-07;1H-Benzimidazole,5-methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-;1H-BENZIMIDAZOLE,6-METHOXY-2-[(R)-[(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-;Tox21_200509;(R)-5-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole;IDI1_032523;SR-01000003003-8;Zepral;73590-58-6 (free form);Prestwick2_000493;Q422210;NCGC00021522-03;Paprazol;Omeprazen;BCP21299;HMS2232B21;6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole;BRD-A55962179-001-08-0;Omerprazole;SAN-15;SMR000058847;Omeprazole delayed-release;BPBio1_000425;NCGC00258063-01;Nexium IV;Omeprazole, solid;OMEPRAZOLE [INN];MLS006010400;DL-462;OMEPRAZOLE (USP IMPURITY);NSC 759192;Lensor;A892647;OMZ;Omeprazole, Pharmaceutical Secondary Standard; Certified Reference Material;SPBio_002306;A19447;5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyrdinyl)-methyl]sulfinyl]-1H-benzimidazole;Prazolit;FT-0652860;AGI-010;6-methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzimidazole;Victrix;FT-0689771;5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl);BRD-A55962179-001-04-9;NCGC00016925-08;Ortanol;HY-B0113;HMS3713D07;NCGC00016925-04;Gasec;Esomeprazole sodium salt;5-Methoxy-2-;NCGC00021522-05;DTXSID6021080;HMS3394G17;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl- 1H-benzimidazole;AC-401;(.+/-.)-Omeprazole;326602-80-6;2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole;OMEPRAZOLE [HSDB];Esomperazole;CAS-73590-58-6;F0001-2386;Result;NCGC00016925-10;Omegast;Omeprazol;161796-78-7;OMEPRAZOLE [USP-RS];H-168/68;OMEPRAZOLE [USP MONOGRAPH];DTXCID501080;STK623746;Tox21_110686;C17H19N3O3S;GTPL4279;KG60484QX9;2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole;HMS2090F11;AMY30573;H 168/68;HMS3677J07;HMS1528I05;H168/68;NC00380;5-methoxy-2-[[(3,5-dimethyl-4-methoxy-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole;HMS2052G17;Prestwick3_000493;HSDB 3575;rac-5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole;5-methoxy-2-(2-(4-methoxy-3,5-dimethylpyridin-2-yl)ethylsulfinyl)-1H-benzo[d]imidazole;Ulzol;Omeprazole, analytical reference material;FT-0673283;BDBM50103597;Omeprazole 13CD3;OMEPRAZOLE COMPONENT OF ZEGERID;Osiren;2,3,5-Trimethylpyridine/Omeprazole;5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1 H-benzimidazole;NCGC00016925-02;Omeprazole (Prilosec);(S)-5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-3H-benzoimidazole;YOSPRALA COMPONENT OMEPRAZOLE;Pharmakon1600-01505693;Omebeta;Omeprazol [INN-Spanish];Prilosec (TN);BIDD:GT0189;OMEPRAZOLE [ORANGE BOOK];HMS3651A11;UPCMLD-DP075;MLS001424148;Omeprazole magnesium;Exter;CHEBI:7772;Aisi'aomeilazuona Esomeprazole Sodium;OMEPRAZOLE (USP MONOGRAPH);Omeprazole - Bio-X;BRD-A55962179-001-20-5;NCGC00021522-04;5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-benzimidazole;SW196942-4;HS-0055;BCP05852;5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole (omeprazole);Omez;HMS2090E16;CS-1868;(RS)-6-METHOXY-2-((4-METHOXY-3,5-DIMETHYLPYRIDIN-2-YL) METHYLSULFINYL)-1H-BENZO(D)IMIDAZOLE;Danlox;NSC751450;SR-01000003003-7;5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole(Omeprazole);5-methoxy 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole;MFCD23135254;Proclor;5-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole;NSC759192;Olit;6-methoxy-2-[[(4methoxy-3,5-dimethyl2-pyridinyl)methyl]sulfinyl]-1h-benzimidazole;5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole;s1389;NSC 751450;Opera_ID_1863;Nilsec;HMS2096D07;Omepradex;(+)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-sulfinyl]-1h-benzimidazole;O0359;AC-4676;5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole;Omeprazole [USAN:USP:INN:BAN:JAN];CHEMBL1503;(+-)-Omeprazole;C07324;Erbolin;OMEPRAZOLE COMPONENT OF YOSPRALA;SR-01000003003;Tedec Ulceral;BDBM50241343;HMS1569D07;( -)-Omeprazole;5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-;ZEGERID COMPONENT OMEPRAZOLE;Omesek;SCHEMBL1191;OMEPRAZOLE [GREEN BOOK];5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphinyl]1H-benzimidazole;BBL028172;MFCD00083192;5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole;5-Methoxy-2-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole;Prestwick0_000493;73590-58-6;6-methoxy-2-[[(4-methoxy3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole;Maybridge4_002645;HMS3269D17;UPCMLD-DP075:001;omeprazolo;H 199;CHEBI:91766;Omeprazole-[d3];(RS)-6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl) methylsulfinyl)-1H-benzo[d]imidazole;A837865;DM-3458;6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole;MLS000069373;CCRIS 7099;Morecon;Z1501475006;NSC-751450;6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole;SY077145;Prestwick1_000493;NCGC00016925-03;Omeprazolum;Antra MUPS;2-(3-methoxy-2,4-dimethylbenzylsulfinyl)-6-methoxy-1H-benzo[d]imidazole;CCG-101130;Omeprazole,(S);AKOS015895343;A02BC01;5-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole;SY009746;NCGC00016925-01;Omeprazole, United States Pharmacopeia (USP) Reference Standard;OMEPRAZOLE [VANDF];Nuclosina;OMEPRAZOLE [USAN];cid_4594;6-methoxy-2-((4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole;Olexin;NCGC00016925-06;OMEPRAZOLE [JAN];Pepticus;119141-88-7;5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole;5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole;Omeprazole, European Pharmacopoeia (EP) Reference Standard;SCHEMBL11995456;Omeprazole Pellets;5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulphinyl]-1H-benzimidazole;A937349;HMS3413J07;Omeprazole, British Pharmacopoeia (BP) Reference Standard;6-methoxy-2-[[(4-methoxy-3,5dimethyl-2-pyridinyl)-methyl]sulfinyl]-1h-benzimidazole;OMEPRAZOLE [USP IMPURITY];5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]benzimidazole;Omeprazole for peak identification, European Pharmacopoeia (EP) Reference Standard;UNII-KG60484QX9;5-METHOXY-2-(((4-METHOXY-3,5,-DIMETHYL-2-PYRIDINYL)-METHYL)SULPHINYL)-1H-BENZIMIDAZOLE;BSPBio_000385;Demeprazol;DB00338;OMEPRAZOLE [MI];SBI-0206896.P001;Sunmark Omeprazole;careone omeprazole;Up and Up Omeprazole;Leader Omeprazole;caring mill omeprazole;Omeprazol (INN-Spanish);Core Values Omeprazole;foster and thrive omeprazole;Good Sense Omeprazole;Harris Teeter Omeprazole;good now omeprazole;Equate omeprazole delayed releaseacid reducer;Exchange Select Omeprazole;Care One Omeprazole;Omeprazole (USAN:USP:INN:BAN:JAN);Equaline Omeprazole;DG health omperazole;equaline omeprazole delayed release;Berkley and Jensen Omeprazole;Omeprazole Dr;Members Mark Omeprazole;Good Neighbor Pharmacy Omeprazole;good sense omeprazole delayed release;24 hr omeprazole;Equate omeprazole delayed release;Topcare Omeprazole;Health Mart Omeprazole;Dg Health Omeprazole;Sound Body Omeprazole;OmeprazoleDR;OMEPRAZOLE (USP-RS);Omeprazolum (INN-Latin);OmeprazoleDelayed Release;Quality Choice Omeprazole;TopCare Omeprazole delayed release;Family Wellness Omeprazole;UlcerGard;Kirkland Signature Omeprazole;welby omeprazole;Signature Care Omeprazole;(S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole;Esomeprazole sodium salt hydrate;119141-88-7 (base);1261395-28-1;6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt;(s)-omeprazole sodium;(S)-Omeprazole sodium salt hydrate;NS00003806;668985-31-7 (Mg);5-Methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole;2 Chloromethyl 3,5 Dimethyl-4-Methoxy Pyridine HCL;Omeprazole for peak identification;BRD-A55962179-001-23-9;1H-benzimidazole, 6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-;PA-32540 component omeprazole;BRD-A55962179-001-21-3;BRD-A55962179-001-22-1;Omeprazole (JP18/USP/INN);BRD-A55962179-001-24-7;JMB29391;Omeprazole-d6;TBB98531;Omeprazole (Standard);Omeprazole - Bio-X trade mark;668985-31-7;HY-B0113R;FM26561;5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole;H 168 68;

MFCD00083192

SUBDBMMJDZJVOS-UHFFFAOYSA-N

1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)

S(C1=NC2C=CC(=CC=2N1)OC)(CC1C(C)=C(C(C)=CN=1)OC)=O

200-659-6

质子泵抑制剂，即壁细胞内H+-K+-ATP酶抑制剂。有强而持久的抑制基础胃酸及食物、五肽胃酸泌素所致的胃酸分泌的作用。显效快，可逆，且无H2受体拮抗剂诱发精神方面的副作用。用于胃及十二指肠溃疡、反流性或糜烂性食管炎、佐-埃二氏综合征等，对用H2受体拮抗剂无效的胃和十二指肠溃疡也有效。

3，5-二甲基-2-羟甲基-4-甲氧基吡啶经氯化，生成2-氯甲基-3，5-二甲基-4-甲氧基吡啶。4-甲氧基1，2-苯二胺和黄原酸钾反应，生成2-巯基-5-甲氧基苯并咪唑，再和上面得到的吡啶衍生物反应，生成2-[(3，5-二甲基-4-甲氧基-2-吡啶基)甲硫基]-5-甲氧基-1H-苯并咪唑，最后在氯仿中，5℃下，用间氯过苯甲酸氧化，得到奥美拉唑。粗品奥美拉唑可用乙腈重结晶。

3628192